Omeros Corporation is a Seattle-based biopharmaceutical firm that specializes in the discovery, development, and commercialization of novel therapeutics aimed at serious conditions. The company boasts a diverse pipeline featuring both protein and small molecule therapies, targeting critical unmet medical needs in areas such as inflammation, complement-mediated diseases, and central nervous system (CNS) disorders. With a strategic focus on orphan indications, Omeros is well-equipped to drive growth and make significant advancements in patient care, positioning itself as a leader in innovative treatment solutions.
Click "Analyze" to generate stock analysis
OMER Price Trend and Signals
OMER Option Volumes & Open Interests (aggregated)
OMER Put Call Ratios and IV (aggregated)
OMER Financials
2025-11-18Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-11-18Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.